Top compounds associated with response to RALY


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib UHNBreast pan-cancer AAC -0.45 0.1
mRNA S-Trityl-L-cysteine FIMM pan-cancer AAC -0.33 0.06
mRNA Epothilone B FIMM pan-cancer AAC -0.32 0.06
mRNA paclitaxel FIMM pan-cancer AAC -0.27 0.04
mRNA Vandetanib FIMM pan-cancer AAC -0.21 0.2
mRNA Doxorubicin gCSI pan-cancer AAC -0.2 5e-05
mRNA Doxorubicin FIMM pan-cancer AAC -0.18 0.2
mRNA paclitaxel gCSI pan-cancer AAC -0.17 0.0009
mRNA Gemcitabine gCSI pan-cancer AAC -0.16 0.003
mRNA Docetaxel gCSI pan-cancer AAC -0.16 0.003
Download CSV